Keywords: Eli Lilly, Cialis, BPH, Benign prostatic hyperplasia, European Commission

European Commission approves Lilly's Cialis for BPH

Article | 31 October 2012

Print This

The European Commission has approved US drug major Eli Lilly’s (NYSE: LLY) Cialis (tadalafil), 5mg for once daily ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in